Core Viewpoint - Dongjie Intelligent Technology Group Co., Ltd. has nominated Mai Qianyu as a candidate for the independent director of its 9th Board of Directors, ensuring compliance with relevant laws and regulations [1][2][3] Group 1: Nomination Process - The nomination was made after a thorough understanding of the candidate's professional background, education, qualifications, and work experience [1] - The candidate has agreed in writing to serve as an independent director [1] - The nomination confirms that the candidate meets the qualifications and conditions set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [1][2] Group 2: Compliance and Qualifications - The candidate does not fall under any disqualifying conditions as per the Company Law of the People's Republic of China [2] - The candidate has participated in training and will obtain the necessary independent director qualification certificate from the Shenzhen Stock Exchange [1][2] - The candidate possesses basic knowledge related to the operation of listed companies and has over five years of relevant work experience [3][4] Group 3: Independence Assurance - The nominee has no close relationships that could affect their independent performance [2][3] - The candidate and their immediate family do not hold more than 1% of the company's issued shares [4] - The candidate has not been subject to any disqualifying measures by the China Securities Regulatory Commission [5][6]

Core Viewpoint - The nomination of Ms. Wu Xiangyang as an independent director candidate for the third board of Shanghai Kaisa Biotechnology Co., Ltd. has been made, with the nominator confirming her qualifications and independence [1][5]. Summary by Sections Nomination and Qualifications - The nominator has fully understood the nominee's professional background, education, titles, work experience, and any significant dishonesty records [1]. - The nominee possesses basic knowledge of listed company operations and has over five years of relevant work experience in law, economics, accounting, finance, or management [1]. Compliance with Regulations - The nominee meets the requirements set forth by the Company Law of the People's Republic of China and the relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [1]. - The nominee has undergone training and obtained certification recognized by the stock exchange [1]. Independence Criteria - The nominee does not fall under any categories that would compromise her independence, such as holding significant shares or having close relationships with major shareholders [2]. - The nominee has no adverse records, including administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [3][4]. Additional Qualifications - The nominee has not been dismissed from previous independent director roles due to attendance issues and has not served as an independent director in more than three domestic listed companies [4]. - The nominee possesses substantial accounting knowledge and experience, holding qualifications such as a certified public accountant or a senior title in accounting, auditing, or financial management [4]. Verification and Assurance - The nominator has verified the nominee's qualifications according to the self-regulatory guidelines of the Shanghai Stock Exchange and guarantees the truthfulness and completeness of the statements made [5].

Core Viewpoint - The company, Henan Tailong Pharmaceutical Co., Ltd., has nominated candidates for independent director positions, ensuring they meet the necessary qualifications and independence criteria as per regulatory requirements [1][5][20]. Summary by Sections Candidate Qualifications - The nominated candidates possess basic knowledge of listed company operations and are familiar with relevant laws and regulations, having over 5 years of necessary work experience in fields such as law, economics, accounting, finance, or management [1][6][20]. - The candidates have completed training and obtained relevant certification recognized by the stock exchange [1][10]. Compliance with Regulations - The candidates' qualifications comply with various legal and regulatory requirements, including the Company Law of the People's Republic of China and the Independent Director Management Measures issued by the China Securities Regulatory Commission [1][11][22]. - The candidates have no conflicts of interest that would affect their independence, as they do not hold significant shares in the company or have close relationships with major shareholders [2][4][12]. Independence Criteria - The candidates do not fall under any disqualifying conditions, such as being employed by the company or its affiliates, holding more than 1% of the company's shares, or having significant business dealings with the company [2][4][8]. - They have not faced any administrative or criminal penalties from the China Securities Regulatory Commission or other judicial authorities in the past 36 months [4][14][23]. Additional Commitments - The candidates have confirmed that they will adhere to all relevant laws, regulations, and stock exchange rules during their tenure as independent directors, ensuring they can make independent judgments without influence from the company or its major shareholders [20][26][30].

上海硅产业集团股份有限公司 独立董事提名人声明与承诺 提名人上海硅产业集团股份有限公司董事会，现提名严杰先生为 上海硅产业集团股份有限公司第三届董事会独立董事候选人，并已充 分了解被提名人职业、学历、职称、详细的工作经历、全部兼职、有 无重大失信等不良记录等情况。被提名人已书面同意出任上海硅产业 集团股份有限公司第三届董事会独立董事候选人（参见该独立董事候 选人声明）。提名人认为，被提名人具备独立董事任职资格，与上海 硅产业集团股份有限公司之间不存在任何影响其独立性的关系，具体 声明并承诺如下： 一、被提名人具备上市公司运作的基本知识，熟悉相关法律、行 政法规、规章及其他规范性文件，具有五年以上法律、经济、会计、 财务、管理等履行独立董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明 材料。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要 求： （一） ； 《中华人民共和国公司法》等关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定 （如适用） ； （五）中共中央组织部《关于进一步规范党政领导干部在企业兼 职（任职）问题的意见》的相关规 ...

Group 1 - The company has nominated Ma Ying as a candidate for the 9th independent director of COFCO Biotechnology Co., Ltd. [2] - The nomination was made after a thorough review of the candidate's qualifications, including professional background, education, and any potential conflicts of interest [2][3] - The nominee has agreed to participate in the latest independent director training and will obtain the necessary certification recognized by the Shenzhen Stock Exchange [3] Group 2 - The nominee meets the qualifications and independence requirements set forth by relevant laws, regulations, and the Shenzhen Stock Exchange [2][4] - The nominee does not have any disqualifying conditions as per the Company Law of the People's Republic of China [3][5] - The nominee has no significant relationships that could affect their independent performance [2][6] Group 3 - The nominee has not been subject to any disqualifications or penalties by the China Securities Regulatory Commission or other regulatory bodies [6][7] - The nominee has not been involved in any major defaults or negative records [6][7] - The nominee's tenure as an independent director in the company does not exceed six years [6][7]

Core Viewpoint - The nomination of Mr. Tang Guoping as an independent director candidate for the 11th Board of Directors of Luyin Investment Group Co., Ltd. has been made, with the nominee meeting all necessary qualifications and independence requirements [1][4]. Summary by Relevant Sections Nominee Qualifications - The nominee possesses basic knowledge of listed company operations, is familiar with relevant laws and regulations, and has over 5 years of experience related to accounting and finance [1]. - The nominee has completed training and obtained certification recognized by the stock exchange [1]. Legal and Regulatory Compliance - The nominee's qualifications comply with various legal and regulatory requirements, including the Company Law of the People's Republic of China and the Independent Director Management Measures by the China Securities Regulatory Commission [1]. - The nominee is not involved in any situations that would compromise independence, such as holding significant shares or positions in related companies [2][3]. Independence Criteria - The nominee does not have any relationships that could affect independence, including family ties to major shareholders or employment with related entities [2][3]. - The nominee has no adverse records, such as administrative penalties or criminal investigations by the China Securities Regulatory Commission within the last 36 months [3][4]. Additional Information - The nominee has not been dismissed from previous independent director roles due to attendance issues and has not served as an independent director for more than three listed companies [4]. - The nominee possesses substantial accounting knowledge and experience, holding qualifications such as a registered accountant and a doctorate in accounting [4]. - The nomination has been verified by the nomination committee of Luyin Investment Group Co., Ltd., confirming no conflicts of interest [4].

Core Viewpoint - The nomination of Zhao Shengtun as an independent director candidate for Hubei Chaozhuo Aviation Technology Co., Ltd. has been made by Li Guangping, who confirms the candidate's qualifications and independence [1][2]. Group 1: Candidate Qualifications - The nominee possesses basic knowledge of listed company operations and has over five years of relevant work experience in law, economics, accounting, finance, or management [1]. - The nominee has completed training and obtained certification recognized by the stock exchange [1]. - The nominee meets the legal and regulatory requirements for independent directors as outlined in various laws and regulations [1]. Group 2: Independence Criteria - The nominee does not have any relationships that could affect their independence, including direct or indirect employment with the company or its affiliates, or significant shareholding [1]. - The nominee has no adverse records, such as administrative penalties or criminal charges from the China Securities Regulatory Commission within the last 36 months [2]. - The nominee has not been dismissed from previous independent director roles due to attendance issues [2]. Group 3: Compliance and Verification - The nominee has undergone a qualification review by the company's third board of directors' nomination committee and is confirmed to meet the requirements [2]. - The nominator guarantees the truthfulness and completeness of the statements made regarding the nominee [3].

Core Viewpoint - The nomination of Li Weifeng as an independent director candidate for Chengdu Yuandong Pharmaceutical Co., Ltd. has been made by the controlling shareholder Wang Ying, who asserts that the candidate meets all necessary qualifications and independence criteria [1][5]. Summary by Relevant Sections Nomination and Qualifications - Wang Ying, the controlling shareholder, has nominated Li Weifeng as an independent director candidate for the fourth board of Chengdu Yuandong Pharmaceutical Co., Ltd. The nominee has agreed to the position and possesses the required professional knowledge and experience [1]. - The nominee has over 5 years of relevant work experience in law, economics, accounting, finance, or management, and has completed the necessary training for independent directors [1]. Compliance with Regulations - The nominee's qualifications comply with various legal and regulatory requirements, including the Company Law of the People's Republic of China and the regulations set forth by the China Securities Regulatory Commission [1]. - Specific regulations regarding the independence of directors have been adhered to, ensuring that the nominee does not fall under any disqualifying conditions [2][3]. Independence Criteria - The nominee is confirmed to be independent, not holding any significant shares or positions that could compromise their impartiality [2][3]. - The nominee has no adverse records, such as administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [4]. Additional Information - The nominee has not served as an independent director in more than three domestic listed companies and has not held the position in Chengdu Yuandong Pharmaceutical Co., Ltd. for more than six years [4]. - The nomination has passed the qualification review by the board's nomination committee, confirming no conflicts of interest exist between the nominator and the nominee [4].

思看科技（杭州）股份有限公司 独立董事提名人声明与承诺 提名人思看科技（杭州）股份有限公司（以下简称"公司"或"思看科技"） 董事会，现提名祝素月为思看科技（杭州）股份有限公司第二届董事会独立董事 候选人，并已充分了解被提名人职业、学历、职称、详细的工作经历、全部兼职、 有无重大失信等不良记录等情况。被提名人已书面同意出任思看科技（杭州）股 份有限公司第二届董事会独立董事候选人(参见该独立董事候选人声明)。提名人 认为，被提名人具备独立董事任职资格，与思看科技（杭州）股份有限公司之间 不存在任何影响其独立性的关系，具体声明并承诺如下： 一、被提名人具备上市公司运作的基本知识，熟悉相关法律、行政法规、规 章及其他规范性文件，具有五年以上法律、经济、会计、财务、管理等履行独立 董事职责所必需的工作经验。 被提名人已经参加培训并取得证券交易所认可的相关培训证明材料。 二、被提名人任职资格符合下列法律、行政法规和部门规章的要求： (一)《中华人民共和国公司法》等关于董事任职资格的规定； (二)《中华人民共和国公务员法》关于公务员兼任职务的规定(如适用); (三)中国证监会《上市公司独立董事管理办法》、上海证券交易所自 ...

Core Viewpoint - The nomination of Xue Wenge as an independent director candidate for the fourth board of Shanghai Xianhui Automation Technology Co., Ltd. has been made, with the nominee meeting all necessary qualifications and independence requirements [1][2]. Summary by Relevant Sections Nomination and Qualifications - The nominee has a solid background in relevant fields, including law, economics, accounting, finance, and management, with over five years of experience necessary for fulfilling independent director responsibilities [1]. - The nominee has completed training and obtained certification recognized by the stock exchange [1]. Compliance with Regulations - The nominee's qualifications comply with various laws and regulations, including the Company Law of the People's Republic of China and the Management Measures for Independent Directors of Listed Companies by the China Securities Regulatory Commission [1]. - The nominee adheres to additional regulations concerning public officials and independent directors, ensuring compliance with multiple regulatory frameworks [1]. Independence Criteria - The nominee does not have any relationships that could affect their independence, including not being an employee or having direct family ties to the company or its major shareholders [1]. - The nominee does not hold more than 1% of the company's shares or have significant business dealings with the company or its controlling shareholders [1]. Record of Conduct - The nominee has no adverse records, including no administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [2]. - There are no ongoing investigations or significant negative records that would disqualify the nominee from serving as an independent director [2].